Oxford BioMedica PLC
LSE:OXB

Watchlist Manager
Oxford BioMedica PLC Logo
Oxford BioMedica PLC
LSE:OXB
Watchlist
Price: 412.5 GBX -1.43% Market Closed
Market Cap: 434.6m GBX
Have any thoughts about
Oxford BioMedica PLC?
Write Note

P/OCF
Price to OCF

-7
Current
-6.3
Median
23.4
Industry
Lower than median
Lower than industry value

Price to Operating Cash Flow (P/OCF) ratio is a valuation multiple that measures the value of a company’s market capitalization relative to the operating cash flow it generates. Some analysts prefer P/OCF over P/E since earnings can be more easily manipulated than cash flows.

P/OCF
-7
=
Market Cap
434.4m GBX
/
Operating Cash Flow
-62.3m GBP
All Countries
Close
Market Cap P/OCF
UK
Oxford BioMedica PLC
LSE:OXB
434.4m GBP -7
FR
Pharnext SCA
OTC:PNEXF
6T USD -236 773.4
US
Abbvie Inc
NYSE:ABBV
300.2B USD 18.2
US
Amgen Inc
NASDAQ:AMGN
158.7B USD 21.9
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
126.8B USD -132.1
US
Gilead Sciences Inc
NASDAQ:GILD
114.8B USD 11.5
US
Epizyme Inc
F:EPE
94.1B EUR -475.1
AU
CSL Ltd
ASX:CSL
137.3B AUD 32
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
88.3B USD 20.3
US
Seagen Inc
F:SGT
39.3B EUR -76.7
NL
argenx SE
XBRU:ARGX
34.1B EUR -137.9
 
UK
Oxford BioMedica PLC
LSE:OXB
Average P/OCF: 20.8
Negative Multiple: -7
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -236 773.4
US
Abbvie Inc
NYSE:ABBV
18.2
US
Amgen Inc
NASDAQ:AMGN
21.9
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -132.1
US
Gilead Sciences Inc
NASDAQ:GILD
11.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -475.1
AU
CSL Ltd
ASX:CSL
32
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
20.3
US
S
Seagen Inc
F:SGT
Negative Multiple: -76.7
NL
argenx SE
XBRU:ARGX
Negative Multiple: -137.9

P/OCF Forward Multiples

Forward P/OCF multiple is a version of the P/OCF ratio that uses forecasted operating cash flow for the P/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/OCF
N/A
2-Years Forward
P/OCF
N/A
3-Years Forward
P/OCF
N/A

See Also

Discover More